|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Medicine (Drs. Jay and Davis) and Pediatrics (Drs. Mansell and Steele), Brown University School of Medicine, Providence, RI; the Center for Statistical Sciences (Mr. Chen), Brown University, Providence, RI; and the Department of Molecular Medicine (Dr. Onuma), Tohoku University, Japan.
Correspondence to: Gregory D. Jay, MD, PhD, Department of Emergency Medicine, Rhode Island Hospital, 593 Eddy St, Providence, RI 02903; e-mail: gregory_jay_MD{at}brown.edu
| Abstract |
|---|
|
|
|---|
Objective: Determination of physician accuracy in measuring PP.
Design: A model of induced PP in a trained healthy subject without respiratory disease was constructed with a fixed inspiratory resistance with measurement of inspiratory air pressure and beat-to-beat BP noninvasively.
Setting: Laboratory.
Participants: Attending physicians from emergency medicine and critical care disciplines who served as consecutive examiners of the trained reference subject generating known PP.
Interventions: A total of 19 attending physicians were assessed for ability in measuring PP by sphygmomanometry and by palpation. The reference subject generated 4° of PP sequentially, with each examiner blinded to the value of negative inspiratory pressure and PP. Examiners first assessed PP qualitatively by palpation, followed by its measurement within 2 min.
Main outcome measure: Proximity of physician-measured PP (PPm) to true PP (PPt).
Results: At inspiratory pressures of - 10, - 15, - 20, and - 25 mm Hg, PPt was 13.7, 16.2, 19.1, and 20.7 mm Hg, respectively (F = 14.8, p < 0.0001; analysis of variance [ANOVA]). At the same pressures, PPm was 13.1, 17.5, 17.7, and 18.0 mm Hg (p > 0.10; ANOVA). Linear regression of PPm against PPt for each examiner revealed a slope (SE) of 0.53 (0.23), and not a 1:1 relationship.
Conclusions: Past and present guidelines do not account for the challenges in measuring PP, especially in tachypneic patients. Sphygmomanometric determination of PP should be augmented by new aids developed through technological innovation.
Key Words: asthma BP physical examination pulsus paradoxus
| Introduction |
|---|
|
|
|---|
10 mm
Hg. This phenomenon is observed in many clinical conditions, including
severe asthma,3
4
5
tension pneumothorax,6
cardiac tamponade,7
COPD,8
croup,9
and massive pulmonary embolism.10
PP
has been researched as an objective measure of severity in
asthma.11
12
It is considered an index of airway
obstruction that has been recommended by authoritative practice
guidelines.13
14
A clear advantage of PP as an asthma
severity index is that PP is a noneffort-dependent measure, in contrast
to peak expiratory flow rate and FEV1. The manual
measurement of PP with a sphygmomanometer is technically demanding.
Neither the interobserver variability of PP determination by
sphygmomanometry15
nor its inherent accuracy has been
researched. This is a relevant flaw in the medical literature, since
the initial National Heart, Lung, and Blood Institute (NHLBI)
guidelines for the diagnosis and management of asthma specified that
patients with a PP > 12 mm Hg deserve hospital
admission.13
Present guidelines14
recommend
PP measurement and do not identify PP thresholds. In this study, we determined if attending physicians can accurately measure PP in an idealized setting both quantitatively (by sphygmomanometry) and qualitatively (by palpation). The examiners were from emergency medicine and critical care disciplines, and served as research subjects. The noninvasive finger BP monitor (FINAPRES; Ohmeda; Englewood, CO) provided the criterion standard for comparison. This device has proven to be a clinically accurate and precise method for tracking changes in BP.16
| Materials and Methods |
|---|
|
|
|---|
Subject and Technique for Induction of PP
PP was induced in a healthy adult by his breathing through a
fixed resistance connected to a two-way nonrebreathing valve (Hans
Rudolph; Kansas City, MO) attached to a manometer (OEM Medical;
Marshalltown, IA). Airflow resistance occurred during inspiration,
whereas expiration was unimpeded. The reference subjects BP and
respiratory plethysmograph were recorded in the sitting position while
he sequentially generated inspiratory mouth pressures from - 10 to
- 25 mm Hg in -5 mm Hg increments. The reference subject controlled
the generated mouth pressures by observing continuous manometer
readings. Inspiration was initiated every 5 s (12 breaths/min) and
accompanied by auditory cues indicating inspiration, thus allowing the
examiners to focus on the ergonomic demands of measuring PP with a
syphgmomanometer. The examiner could hear these cues despite the
presence of a stethoscope. The reference subject was unable to
randomize the degrees of PP that were instead incrementally increased.
Examiners were blinded to this information.
Noninvasive BP Measurements
The FINAPRES device was used to noninvasively acquire a
continuous BP reading. This device approximates invasive arterial BP
monitoring and has been validated in previous study.17
Data from the FINAPRES was digitized by an analog-to-digital converter
(model MP100; Biopac Systems; Santa Barbara, CA) connected to a
computer (Macintosh Power PC 6100; Macintosh; Cupertino, CA).
Determination of Respiratory Phase
Chest wall movements were recorded using a piezoelectric
respiration transducer (Crystal Trace; Pro-Tech Service; Woodenville,
WA) with a stretchable hook-and-loop-fastener strap placed around the
chest at the nipple level. A differential amplifier (model DA100A;
Biopac Systems) was used for signal amplification. The amplified
respiratory signal was digitized by the same analog-to-digital
converter used above.
PP Measurement by Physicians
While the BP was monitored on the left middle finger of the
reference subject by the FINAPRES device, an examiner measured BP with
a syphgmomanometer at the right brachial artery for induced PP at each
inspiratory pressure. Examiners first determined if any PP was present
via palpation with a yes/no format, followed by PP estimation via
syphgmomanometry within 2 min for each of four induced values of PP in
separate sessions. Examiners compared observed systolic pressure
between inspiration and expiration, and subtracted the two values.
Examiners were told to identify a PP value that appeared reproducible
after at least three attempts. This was defined as PP by us to all
examiners prior to measurement. Examiners used the same
syphgmomanometer and were allowed to familiarize themselves with its
operation. The examiners were queried in regards to their knowledge of
PP and their ability to accurately measure PP. Prior to data
collection, both the FINAPRES device and syphgmomanometer were used to
confirm that no difference in systolic BP existed between extremities.
True PP Determination
PP was defined as the lowest inspiratory systolic BP subtracted
from the peak expiratory systolic pressure. Mean and SD of continuous
PP measurements in 2 min were calculated for each induced PP for each
examiner.
Statistical Analysis
Data of induced PP were classified by inspiratory pressure and
evaluated by box plot analysis and analysis of variance (ANOVA). Under
the assumption that the repeated measures within each examiner were
exchangeable, separate analyses of repeated measure data were done by
linear regression and logistic regression for the examiners value of
measured PP (PPm) and the qualitative assessment of PP (palpation). A
probability of palpation was defined as the number of correct
identifications of PP by palpation divided by the total number of
examiners for a given true PP (PPt). The value of PPt served as the
predictive variable.
Computations were done using the statistical software packages (SAS; SAS Institute; Cary, NC; and S-PLUS; MathSoft; Cambridge, MA). The subroutine within SAS was PROC MIXED. Power analysis revealed that a minimum of 18 examiners were needed in order to achieve 80% power in determining the relationship between PPm and PPt.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The present results indicate that measuring PP under idealized conditions, which included quiet surroundings, slow respiratory rate, and auditory cues of respiratory phase, may be problematic. Physicians have already recognized that PP determination by sphygmomanometry is technically demanding and time consuming. However, the literature does not contain a systematic study of physicians ability to measure PP accurately. Assessing for PP is a useful adjunct to physical examination among patients with asthma or in consideration of life-threatening processes, such as cardiac tamponade. Currently, there are no aids in determining PP quantitatively and noninvasively.
The results are both relevant and timely. The NHLBI has revised expert guidelines for the evaluation of patients presenting with acute asthma.14 The recommendation by the expert panel of PP as a severity measure is based on a solid body of evidence3 5 11 that correlates the physical sign with indices of expiratory flow obstruction, such as FEV1. However, the major mechanical consequence of acute asthma is now thought to be increased inspiratory muscle elastic loading as a result of dynamic lung hyperinflation.19 20 PP is a measure of inspiratory impedance as it affects pleural pressure, left ventricular stroke volume, and right ventricular output.21 Therefore, measurement of PP is pertinent to respiratory distress,22 inspiratory muscle fatigue, air leak, and other mechanical consequences of dynamic hyperinflation during acute asthma.
The present findings are perhaps most germane to the assessment of
childhood asthma. Children < 5 years old are rarely able to perform
peak expiratory flow rate and spirometry. PP, as an index of severity
that does not require active cooperation, could be particularly
applicable to acute asthma in infants and children. Unfortunately, high
respiratory rates (sometimes > 60 breaths/min) in these settings are
likely to confound measurements of PP further, producing even more
variability than we found at a respiratory rate of 12 breaths/min.
Previous NHLBI guidelines recommended patient admission for PP
12
mm Hg. The validity of this threshold was previously investigated among
children presenting with acute asthma and treated by pediatric
emergency medicine specialists blinded to all severity
measures.12
Admitted and successfully discharged patients
presented to the emergency department with a PP > 11 mm Hg and < 11
mm Hg, respectively. Despite the fact that the NHLBI guideline PP
admission threshold was not validated in an outpatient setting and
relies on manual PP determination, 12 mm Hg is a good approximation to
11 mm Hg,12
a value arrived at using the arterial
plethysmographic techniques illustrated in the present report.
The present results indicate that PP measured qualitatively by palpation may also be unreliable. A number of the physicians examined detected a palpable PP near the mean PPt of 16.2 mm Hg, but failed to measure its amplitude successfully by BP cuff. These same physicians were inconsistent in detecting PP as PPt increased. Pulse oximeters equipped with a visual plethysmographic display could be used as aids23 24 to confirm the presence of a palpable PP. This commonly available equipment is perhaps underutilized.
Assessment for PP is part of a thorough physical examination and should not necessarily be abandoned. Traditional teaching in US medical schools and some postgraduate training programs includes the expectation that physicians have the ability to measure PP with a BP cuff. Perhaps the key to this test is not to be physiologically precise, but rather to detect PP of sufficient magnitude that would influence some type of clinical decision making. The physician examiners in this study demonstrated a trend in accurately detecting PP qualitatively by palpation as PPt increased. These data and the subjective clinical experiences of the investigators (which inspired the study) suggest that simply detecting the presence of a paradoxical pulse by palpation could be more clinically meaningful than a quantitative measure that is likely erroneous. We also recommend that patients suspected of having a paradoxical pulse be studied by other noninvasive means, such as Doppler echocardiography, which may reveal variations between mitral and tricuspid flow. Appropriate future studies could be the determination of the receiver operator curve characteristic in palpating for an action level of PPt or the minimum PP detectable by optical plethysmography. Possible limitations not accounted for in the study design include our determination of PPt and PPm on different extremities. No difference in systolic pressure between extremities was confirmed at baseline, but whether a difference in PP exists between extremities is unknown.
| Acknowledgements |
|---|
| Footnotes |
|---|
Received for publication September 13, 1999. Accepted for publication February 18, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Rayner, F. Trespalacios, J. Machan, V. Potluri, G. Brown, L. M. Quattrucci, and G. D. Jay Continuous noninvasive measurement of pulsus paradoxus complements medical decision making in assessment of acute asthma severity. Chest, September 1, 2006; 130(3): 754 - 765. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |